Morgan Stanley
-
Notable Analyst Rating Changes 11/12: ETN, NVDA, LDK, AH Upgraded; BA, STZ, NBL, MO Downgraded
-
Morgan Stanley Initiates Coverage on Accretive Health (AH) with a Equalweight
-
Accretive Health (AH) IPO Trades Higher
-
Accretive Health (AH) Prices Smaller IPO at $12, Below Expected Range
-
Accretive Health (AH) Files $200M IPO
